haematology
Blood cancers

Curing acute promyelocytic leukaemia: ‘Blunderbuss, vitamins, and a poison chaser’

Professor Harry Iland, from Royal Prince Alfred Hospital in Sydney, told the HAA meeting how the treatment of acute promyelocytic leukaemia (APL) has evolved from non-selective ‘blunderbuss’ therapy anthracyclines through the addition of vitamin A-based retinoids and most recently, arsenic. Delivering the Carl de Gruchy Oration, Professor Iland explained how the cytogenetic and molecular abnormalities ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic